Business
Digipath Files Patent Application for Test to Distinguish Hemp from Drug-type Cannabis
Digipath Files Patent Application for Test to Distinguish Hemp from Drug-type Cannabis.
About this update from Hypha Labs, Inc.
[{"type":"text","content":"\n\n\n\nDigipath Files Patent Application for Test to Distinguish Hemp from Drug-type Cannabis\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nDigipath Files Patent Application for Test to Distinguish Hemp from Drug-type Cannabis\nAddresses Recent Request For Proposal Issued by DEA\nPR Newswire\nLAS VEGAS, April 9, 2019\n\n\n\nLAS VEGAS, April 9, 2019 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that in collaboration with VSSL of Kelowna, BC, has filed a provisional patent application for a Field Testing Kit that can quickly determine whether a plant sample is actually hemp, drug-type THC or drug-type CBD.\n\n \n \n\n \nCurrently the only recourse for law enforcement to make a determination of what is being transported across state lines is lab based analytical testing of the mature plants for their THC content to come in under the 0.3% THC level. The Digipath-VSSL simple genetic field test will allow for a DNA-based assay to clearly designate if plant material at any stage of growth is industrial hemp or drug-type CBD and NOT drug-type THC. Inability to determine what a sample is, and if it is in compliance with prevailing law, has been an enormous problem for law enforcement, hemp farmers, and others looking to ensure full compliance. A recent High Times article details this problem, noting an instance where a fully-compliant hemp shipment was wrongfully seized due to a failure to properly identify the cargo.\nAs one of the premier testing laboratories in the United States, Digipath is looking to expand on its services with a mobile product to serve the market need for a test to distinguish the two cannabis strains. The patent application filing comes following a recent Request for Proposal for \"Hemp/Marijuana Field Test Kits\" posted by the United States Drug Enforcement Agency. The request reads as follows:\n\"The field test kit must provide specificity ...